385 related articles for article (PubMed ID: 21929848)
1. Banking human umbilical cord-derived mesenchymal stromal cells for clinical use.
Gong W; Han Z; Zhao H; Wang Y; Wang J; Zhong J; Wang B; Wang S; Wang Y; Sun L; Han Z
Cell Transplant; 2012; 21(1):207-16. PubMed ID: 21929848
[TBL] [Abstract][Full Text] [Related]
2. Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation.
Friedman R; Betancur M; Boissel L; Tuncer H; Cetrulo C; Klingemann H
Biol Blood Marrow Transplant; 2007 Dec; 13(12):1477-86. PubMed ID: 18022578
[TBL] [Abstract][Full Text] [Related]
3. Human umbilical cord mesenchymal stem cells: osteogenesis in vivo as seed cells for bone tissue engineering.
Diao Y; Ma Q; Cui F; Zhong Y
J Biomed Mater Res A; 2009 Oct; 91(1):123-31. PubMed ID: 18767055
[TBL] [Abstract][Full Text] [Related]
4. Characterization of human umbilical cord mesenchymal stem cells following tissue mass culture.
Yang LM; Liu Y; Zhao J; Hao LM; Huang KX; Jiang WH
Cell Mol Biol (Noisy-le-grand); 2014 Mar; 60(1):12-8. PubMed ID: 24606723
[TBL] [Abstract][Full Text] [Related]
5. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the chondrogenic potential and secretome of mesenchymal stem cells derived from human umbilical cord stroma.
Arufe MC; De la Fuente A; Mateos J; Fuentes I; De Toro FJ; Blanco FJ
Stem Cells Dev; 2011 Jul; 20(7):1199-212. PubMed ID: 20977334
[TBL] [Abstract][Full Text] [Related]
7. Fetal mesenchymal stem cells derived from human umbilical cord sustain primitive characteristics during extensive expansion.
Jo CH; Kim OS; Park EY; Kim BJ; Lee JH; Kang SB; Lee JH; Han HS; Rhee SH; Yoon KS
Cell Tissue Res; 2008 Dec; 334(3):423-33. PubMed ID: 18941782
[TBL] [Abstract][Full Text] [Related]
8. Isolation and proliferation of umbilical cord tissue derived mesenchymal stem cells for clinical applications.
Van Pham P; Truong NC; Le PT; Tran TD; Vu NB; Bui KH; Phan NK
Cell Tissue Bank; 2016 Jun; 17(2):289-302. PubMed ID: 26679929
[TBL] [Abstract][Full Text] [Related]
9. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy.
Haack-Sorensen M; Friis T; Bindslev L; Mortensen S; Johnsen HE; Kastrup J
Scand J Clin Lab Invest; 2008; 68(3):192-203. PubMed ID: 17852829
[TBL] [Abstract][Full Text] [Related]
10. Promising new potential for mesenchymal stem cells derived from human umbilical cord Wharton's jelly: sweat gland cell-like differentiative capacity.
Xu Y; Huang S; Ma K; Fu X; Han W; Sheng Z
J Tissue Eng Regen Med; 2012 Aug; 6(8):645-54. PubMed ID: 21916019
[TBL] [Abstract][Full Text] [Related]
11. Comparison of human mesenchymal stem cells derived from adipose and cord tissue.
Choudhery MS; Badowski M; Muise A; Harris DT
Cytotherapy; 2013 Mar; 15(3):330-43. PubMed ID: 23318344
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of mesenchymal stem cells from whole human umbilical cord applying a single enzyme approach.
Zhang H; Zhang B; Tao Y; Cheng M; Hu J; Xu M; Chen H
Cell Biochem Funct; 2012 Dec; 30(8):643-9. PubMed ID: 22777760
[TBL] [Abstract][Full Text] [Related]
13. Osteoinduction in umbilical cord- and palate periosteum-derived mesenchymal stem cells.
Caballero M; Reed CR; Madan G; van Aalst JA
Ann Plast Surg; 2010 May; 64(5):605-9. PubMed ID: 20395805
[TBL] [Abstract][Full Text] [Related]
14. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease.
Weiss ML; Medicetty S; Bledsoe AR; Rachakatla RS; Choi M; Merchav S; Luo Y; Rao MS; Velagaleti G; Troyer D
Stem Cells; 2006 Mar; 24(3):781-92. PubMed ID: 16223852
[TBL] [Abstract][Full Text] [Related]
15. Effect of mechanical stimulation on the differentiation of cord stem cells.
Kang MN; Yoon HH; Seo YK; Park JK
Connect Tissue Res; 2012; 53(2):149-59. PubMed ID: 22149641
[TBL] [Abstract][Full Text] [Related]
16. Two steps to functional mesenchymal stromal cells for clinical application.
Bartmann C; Rohde E; Schallmoser K; Pürstner P; Lanzer G; Linkesch W; Strunk D
Transfusion; 2007 Aug; 47(8):1426-35. PubMed ID: 17655587
[TBL] [Abstract][Full Text] [Related]
17. Lentivirus-modified human umbilical cord mesenchymal stem cells maintain their pluripotency.
Qian H; Zhang X; Xu W; Zhu W; Cao H; Chen Y; Xu X; Wang M; Xie Y; Sun J
Biotechnol Appl Biochem; 2010 Feb; 55(1):53-62. PubMed ID: 19961436
[TBL] [Abstract][Full Text] [Related]
18. Effects of storage solutions on the viability of human umbilical cord mesenchymal stem cells for transplantation.
Chen Y; Yu B; Xue G; Zhao J; Li RK; Liu Z; Niu B
Cell Transplant; 2013; 22(6):1075-86. PubMed ID: 23043973
[TBL] [Abstract][Full Text] [Related]
19. Immune properties of human umbilical cord Wharton's jelly-derived cells.
Weiss ML; Anderson C; Medicetty S; Seshareddy KB; Weiss RJ; VanderWerff I; Troyer D; McIntosh KR
Stem Cells; 2008 Nov; 26(11):2865-74. PubMed ID: 18703664
[TBL] [Abstract][Full Text] [Related]
20. Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties and differentiation of human Wharton's jelly stem cells.
Fong CY; Subramanian A; Biswas A; Gauthaman K; Srikanth P; Hande MP; Bongso A
Reprod Biomed Online; 2010 Sep; 21(3):391-401. PubMed ID: 20638335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
